Key result
Inhibition of neuronal nitric oxide synthase (nNOS) decreased state IIIu respiration in cardiac mitochondria and both state III and state IIIu respiration in brain mitochondria.
Why the study?
Although evidence supports the presence of nitric oxide synthase in mitochondria, the functional role of mtNOS in regulating mitochondrial respiration remains unclear.
Mitochondrial nNOS positively regulates respiration in isolated heart and brain mitochondria, challenging the existing dogma that NO is inhibitory to mitochondrial respiration.
Challenges view of NO as uniform mitochondrial inhibitor; hypothesis-generating for nNOS-targeted therapies in heart and brain disease.
Nitric oxide (NO) is known to exert inhibitory control on mitochondrial respiration in the heart and brain. Evidence supports the presence of NO synthase (NOS) in the mitochondria (mtNOS) of cells; however, the functional role of mtNOS in the regulation of mitochondrial respiration is unclear. Our objective was to examine the effect of NOS inhibitors on mitochondrial respiration and protein S-nitrosylation. Freshly isolated cardiac and brain nonsynaptosomal mitochondria were incubated with selective inhibitors of neuronal (nNOS; ARL-17477, 1 µmol/L) or endothelial [eNOS; N5-(1-iminoethyl)-l-ornithine, NIO, 1 µmol/L] NOS isoforms. Mitochondrial respiratory parameters were calculated from the oxygen consumption rates measured using Agilent Seahorse XFe24 analyzer. Expression of NOS isoforms in the mitochondria was confirmed by immunoprecipitation and Western blot analysis. In addition, we determined the protein S-nitrosylation by biotin-switch method followed by immunoblotting. nNOS inhibitor decreased the state IIIu respiration in cardiac mitochondria and both state III and state IIIu respiration in brain mitochondria. In contrast, eNOS inhibitor had no effect on the respiration in the mitochondria from both heart and brain. Interestingly, NOS inhibitors reduced the levels of protein S-nitrosylation only in brain mitochondria, but nNOS and eNOS immunoreactivity was observed in the cardiac and brain mitochondrial lysates. Thus, the effects of NOS inhibitors on S-nitrosylation of mitochondrial proteins and mitochondrial respiration confirm the existence of functionally active NOS isoforms in the mitochondria. Notably, our study presents first evidence of the positive regulation of mitochondrial respiration by mitochondrial nNOS contrary to the current dogma representing the inhibitory role attributed to NOS isoforms. NEW & NOTEWORTHY Existence and the role of nitric oxide synthases in the mitochondria are controversial. We report for the first time that mitochondrial nNOS positively regulates respiration in isolated heart and brain mitochondria, thus challenging the existing dogma that NO is inhibitory to mitochondrial respiration. We have also demonstrated reduced protein S-nitrosylation by NOS inhibition in isolated mitochondria, supporting the presence of functional mitochondrial NOS.
No takes yet. Share an insight, caveat, or question.
Sakamuri et al. (2020) studied this question. NOS inhibitors (ARL-17477 and NIO) was evaluated on Mitochondrial respiration and protein S-nitrosylation. Inhibition of neuronal nitric oxide synthase (nNOS) decreased state IIIu respiration in cardiac mitochondria and both state III and state IIIu respiration in brain mitochondria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: